Quarterly Financial Information (Unaudited)

12 Months Ended

Dec. 31, 2013

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Information (Unaudited)

Quarterly Financial Information (Unaudited)

(in thousands, except per share amounts)
Year ended December 31, 2013	First Quarter					Second Quarter			Third Quarter					Fourth Quarter
Net revenues	$	415,591				$	414,424		$	410,492				$	486,137
Gross profit	194,018					195,477			190,014					204,955
(Loss) income before income taxes and equity in net earnings (loss) of CareCentrix	(212,472		)	(2	)	11,392			6,852					(443,844		)	(2)
(Loss) net income attributable to Gentiva shareholders (1)	(207,177		)	(2	)	6,347			3,720					(401,884		)	(2)
Earnings Per Share:
Net (loss) income attributable to Gentiva shareholders:
Basic	$	(6.73	)			$	0.21		$	0.12				$	(11.46	)
Diluted	$	(6.73	)			$	0.20		$	0.12				$	(11.46	)
Weighted average shares outstanding:
Basic	30,785					30,941			31,037					35,054
Diluted	30,785					31,239			31,532					35,054
Year ended December 31, 2012	First Quarter					Second Quarter			Third Quarter					Fourth Quarter
Net revenues	$	435,652				$	427,691		$	424,444				$	425,017
Gross profit	202,791					204,954			200,555					195,763
Income (loss) before income taxes and equity in net earnings (loss) of CareCentrix	7,582					23,818		(3)	(2,678		)	(2	)	18,510			(3)
Net income (loss) attributable to Gentiva shareholders (1)	4,840					13,909		(3)	(523		)	(2	)	8,570			(3),(4)
Earnings Per Share:
Net income (loss) attributable to Gentiva shareholders:
Basic	$	0.16				$	0.46		$	(0.02	)			$	0.28
Diluted	$	0.16				$	0.46		$	(0.02	)			$	0.28
Weighted average shares outstanding:
Basic	30,724					30,338			30,423					30,548
Diluted	30,959					30,446			30,423					30,891

(1) (Loss) income before income taxes and equity in net earnings (loss) of CareCentrix for each of the 2013 and 2012 quarters includes charges relating to cost savings initiatives and other restructuring, integration and acquisition activities and legal settlements as follows (in thousands):

	First Quarter		Second Quarter		Third Quarter		Fourth Quarter
Year ended December 31, 2013	$	141	$	744	$	1,699	$	24,955
Year ended December 31, 2012	$	5,391	$	25	$	53	$	201

(2) For the fourth quarter of 2013, the Company recorded non-cash impairment charges relating to the goodwill and intangibles of its Hospice segment of approximately $379.8 million and $6.3 million, respectively, for the year 2013.

For the first quarter of 2013, the Company recorded non-cash impairment charges associated with goodwill and other long-lived assets of $224.3 million. This charge was the result of (i) changes in the Company's business climate, (ii) uncertainties around Medicare reimbursement as the federal government worked to reduce the federal deficit, (iii) a write-down of software and (iv) a change in the estimated fair value of real estate. See Notes 8 and 9.

For the third quarter of 2012, the Company recorded non-cash impairment charges associated with a write-off of its trade name intangibles of $19.1 million in connection with the Company's initiative to re-brand its operations under the Gentiva name.

(3) For the fourth quarter of 2012, income (loss) before income taxes and equity in net earnings of CareCentrix, includes a $2.6 million pre-tax gain related to the sale of the Phoenix area hospice operations.

For the second quarter of 2012, income (loss) before income taxes and equity in net earnings of CareCentrix, includes a $5.4 million pre-tax gain associated with the sale of (i) the Gentiva consulting business and (ii) the sale of eight home health branches and four hospice branches in Louisiana.

(4) In anticipation of a settlement of claims alleged by the owner of CareCentrix and working capital adjustments as set forth in the stock purchase agreement, during the fourth quarter of 2012, the Company recorded a $6.5 million adjustment to the seller financing note receivable to reflect its revised estimated fair value of $3.4 million, which is recorded in equity in net loss of CareCentrix.